Interferon Alfa-2B was predicted to be a potentially effective drug for VKH disease treatment by targeting IFN-γ and IL-6, which warrants further experimental and clinical investigations. The gene discussed is IL6; the disease is Vogt-Koyanagi-Harada disease.